pharmaceutical investing Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox
EraNova Announces Positive Preliminary Economic Assessment for the Adanac Molybdenum Project: After-Tax NPV of $714.4 Million and 23.5% IRR
